Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 1
1962 1
1963 2
1964 3
1965 3
1966 1
1967 2
1968 2
1969 2
1970 2
1971 3
1972 2
1973 2
1974 2
1975 1
1977 1
1978 1
1979 1
1980 2
1982 4
1983 3
1984 7
1985 7
1986 4
1987 4
1988 3
1989 5
1990 2
1991 2
1992 3
1993 3
1994 6
1995 5
1997 4
1998 1
1999 4
2000 3
2001 1
2002 1
2003 3
2004 1
2005 3
2006 10
2007 4
2008 7
2009 4
2010 7
2011 1
2012 3
2013 19
2014 11
2015 12
2016 14
2017 12
2018 17
2019 14
2020 16
2021 19
2022 17
2023 14
2024 9
2025 19
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

315 results

Results by year

Filters applied: . Clear all
Page 1
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
Müller F, Taubmann J, Bucci L, Wilhelm A, Bergmann C, Völkl S, Aigner M, Rothe T, Minopoulou I, Tur C, Knitza J, Kharboutli S, Kretschmann S, Vasova I, Spoerl S, Reimann H, Munoz L, Gerlach RG, Schäfer S, Grieshaber-Bouyer R, Korganow AS, Farge-Bancel D, Mougiakakos D, Bozec A, Winkler T, Krönke G, Mackensen A, Schett G. Müller F, et al. Among authors: bucci l. N Engl J Med. 2024 Feb 22;390(8):687-700. doi: 10.1056/NEJMoa2308917. N Engl J Med. 2024. PMID: 38381673
Bispecific T cell engager therapy for refractory rheumatoid arthritis.
Bucci L, Hagen M, Rothe T, Raimondo MG, Fagni F, Tur C, Wirsching A, Wacker J, Wilhelm A, Auger JP, Pachowsky M, Eckstein M, Alivernini S, Zoli A, Krönke G, Uderhardt S, Bozec A, D'Agostino MA, Schett G, Grieshaber-Bouyer R. Bucci L, et al. Nat Med. 2024 Jun;30(6):1593-1601. doi: 10.1038/s41591-024-02964-1. Epub 2024 Apr 26. Nat Med. 2024. PMID: 38671240
BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease.
Hagen M, Bucci L, Böltz S, Nöthling DM, Rothe T, Anoshkin K, Raimondo MG, Tur C, Wirsching A, Wacker J, Düsing C, Distler JHW, Kuwert T, Bozec A, Ramming A, Schett G, Grieshaber-Bouyer R. Hagen M, et al. Among authors: bucci l. N Engl J Med. 2024 Sep 5;391(9):867-869. doi: 10.1056/NEJMc2408786. N Engl J Med. 2024. PMID: 39231353 No abstract available.
CD19-CAR T-cell therapy induces deep tissue depletion of B cells.
Tur C, Eckstein M, Velden J, Rauber S, Bergmann C, Auth J, Bucci L, Corte G, Hagen M, Wirsching A, Grieshaber-Bouyer R, Reis P, Kittan N, Wacker J, Rius Rigau A, Ramming A, D'Agostino MA, Hartmann A, Müller F, Mackensen A, Bozec A, Schett G, Raimondo MG. Tur C, et al. Among authors: bucci l. Ann Rheum Dis. 2025 Jan;84(1):106-114. doi: 10.1136/ard-2024-226142. Epub 2025 Jan 2. Ann Rheum Dis. 2025. PMID: 39874224
Effects of different B-cell-depleting strategies on the lymphatic tissue.
Tur C, Eckstein M, Bucci L, Auth J, Bergmann C, Rauber S, Hagen M, Nöthling DM, Böltz S, Wirsching A, Tascilar K, Fagni F, Corte G, Rius Rigau A, Qin Y, Garantziotis P, Taubmann J, Wacker J, Ramming A, D Agostino MA, Rauch S, Hartmann A, Müller F, Mackensen A, Grieshaber-Bouyer R, Schett G, Bozec A, Raimondo MG. Tur C, et al. Among authors: bucci l. Ann Rheum Dis. 2025 Dec;84(12):2065-2074. doi: 10.1016/j.ard.2025.06.2120. Epub 2025 Jul 11. Ann Rheum Dis. 2025. PMID: 40651933 Free article.
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease.
Bucci L, Böltz S, Hagen M, Tur C, Nöthling DM, Rothe T, Wirsching A, Auth J, Wacker J, Eckstein M, Alivernini S, Bozec A, Bergmann C, D'Agostino MA, Munoz L, Rech J, Kihm L, Raimondo MG, Schett G, Grieshaber-Bouyer R. Bucci L, et al. N Engl J Med. 2025 Oct 16;393(15):1544-1547. doi: 10.1056/NEJMc2506740. N Engl J Med. 2025. PMID: 41092336 No abstract available.
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells.
Müller F, Wirsching A, Hagen M, Völkl S, Tur C, Raimondo MG, Taubmann J, Bucci L, Zhang L, Kretschmann S, Aigner M, Eckstein M, Spörl S, Kharboutli S, Böltz S, Atzinger A, Munoz L, Schett G, Mackensen A, Grieshaber-Bouyer R. Müller F, et al. Among authors: bucci l. Nat Med. 2025 Jun;31(6):1793-1797. doi: 10.1038/s41591-025-03718-3. Epub 2025 Apr 17. Nat Med. 2025. PMID: 40245922 Free PMC article.
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study.
Hagen M, Müller F, Wirsching A, Kharboutli S, Spoerl S, Düsing C, Krickau T, Metzler M, Völkl S, Aigner M, Kretschmann S, Vasova I, Saake M, Schliep S, Kubacki T, Hunzelmann N, Bucci L, Taubmann J, Bergmann C, Györfi AH, Dietrich S, Distler JHW, Grieshaber-Bouyer R, Mackensen A, Schett G. Hagen M, et al. Among authors: bucci l. Lancet Rheumatol. 2025 Jun;7(6):e424-e433. doi: 10.1016/S2665-9913(25)00091-8. Epub 2025 Apr 30. Lancet Rheumatol. 2025. PMID: 40318690 Free article.
[Anorexia nervosa ].
Bucci L, Cabras A. Bucci L, et al. Riv Eur Sci Med Farmacol. 1993 Sep-Dec;15(5-6):223-6. Riv Eur Sci Med Farmacol. 1993. PMID: 7761675 Review. Italian.
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.
Müller F, Hagen M, Wirsching A, Kharboutli S, Aigner M, Völkl S, Kretschmann S, Tascilar K, Taubmann J, Bucci L, Raimondo MG, Bergmann C, Rothe T, Corte G, Tur C, Muñoz L, Böltz S, Schuster L, Hartmann F, Garantziotis P, Spörl S, Vasova I, Gerbitz A, Spriewald B, Kiener H, Giannarelli D, Locatelli F, D'Agostino MA, Hanssens L, Miltenyi S, Bozec A, Grieshaber-Bouyer R, Mackensen A, Schett G. Müller F, et al. Among authors: bucci l. Nat Med. 2026 Mar;32(3):1142-1151. doi: 10.1038/s41591-025-04185-6. Epub 2026 Jan 7. Nat Med. 2026. PMID: 41501497 Free PMC article. Clinical Trial.
315 results